Abstract
The anticancer effects of ceramide have been reported in many types of cancers but less in lung cancer. In this study, we used C2-ceramide to further investigate its possible anticancer effects and mechanisms on non-small cell lung cancer (NSCLC) H1299 cells. The result of cell proliferation in terms of trypan blue assay showed high dose of C2-ceramide inhibited cell survival after 24 h treatment. The flow cytometry-based assays indicated the effect of apoptosis, chromatin condensation, and G1 arrest in terms of Annexin V/propidium iodide (PI), DAPI, and PI stainings, respectively. Moreover, the decreased protein level of p-Akt, p-NFκB, survivin and cyclin A2 were detected by Western blot assay. Taken together, these results indicated the antiproliferative effect of C2-ceramide is majorly responsible for cell apoptosis in lung cancer H1299 cells.
Original language | English |
---|---|
Article number | 1 |
Journal | Cancer Cell International |
Volume | 14 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 6 2014 |
Keywords
- Apoptosis
- Ceramides
- Lung cancer
- NSCLC
- cyclin A2
- p-Akt
- p-NFκB
- survivin
ASJC Scopus subject areas
- Oncology
- Genetics
- Cancer Research